Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment
Via News Direct
Exposures Product Safety
Tickers NLSP
Bristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review
Via Benzinga
Exposures Product Safety
Tickers BMY
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
Via Benzinga
Exposures Product Safety
Tickers MDT
FDA Clears Entrada Therapeutics' Early-Stage For Potential Treatment Of Duchenne Muscular Dystrophy
Via Benzinga
Exposures Product Safety
Tickers TRDA
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients
Via Benzinga
Exposures COVID-19 Product Safety
Tickers IVVD
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery
Via Benzinga
Exposures Product Safety
Tickers GKOS
Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version
Via Benzinga
Exposures COVID-19 Product Safety
Tickers CODX
REMSleep Prepares to Launch New FDA Cleared CPAP Pillows Mask to Market
Via NewMediaWire
Exposures Product Safety
Tickers RMSL
REMSleep Prepares to Launch New FDA Cleared CPAP Pillows Mask to Market
Via TheNewswire.com
Exposures Product Safety
Tickers RMSL
From Vehicle Factory Codes to Smart Decisions: The Power of VIN Decoders
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Skincare Brands US Market Entry Support: Business Registration, Marketing Update
Via Press Release Distribution Service
Exposures Product Safety
FDA Approves Mirum Pharmaceuticals' Drug As First For Genetic Disorder With Inability To Break-Down Cholesterol
Via Benzinga
Exposures Product Safety
Tickers MIRM
What's Going On With Hims & Hers Health Stock Today?
Via Benzinga
Topics Economy
Exposures Product Safety Supply Chain
Tickers HIMS
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage
Via Investor's Business Daily
Exposures Product Safety
Tickers HIMS LLY NVO
Elon Musk's Tesla Recalls Nearly 380,000 Model 3, Y Vehicles In US Over Loss Of Power Steering Assist Concerns
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
AirAllergen Reinforces Commitment to Customer Service and Education in Indoor Air Quality
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
iQure Pharma, Zefit’s Partner, Secures FDA Orphan Drug Designation for Dravet Syndrome Treatment
Via AB Newswire
Exposures Product Safety
International Process Solutions Offers Onsite Temperature Calibration Services
Via AB Newswire
Exposures Product Safety
ImmunityBio Surges On FDA Green Light For Expanded Bladder Cancer Vaccine Access — Retail Buzz Intensifies
Via Stocktwits
Exposures Product Safety
Tickers IBRX MRK
Roger B. Bagwell, Ph.D., is named the Actuated Medical Director, Neural Device Operations
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder
Via Benzinga
Exposures Product Safety
Tickers HRMY
Medcrypt Unveils Enhanced Helm SBOM Vulnerability Management Tool: The First Industry-Specific Solution for Medical Device Manufacturers
Via PRUnderground
Exposures Product Safety
Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
Via MarketBeat
Exposures Product Safety
Tickers SLDB SRPT
Moderna: A Generational Opportunity for Investors in 2025
Via MarketBeat
Exposures COVID-19 Product Safety
Tickers MRNA
DOGE Reportedly Fires FDA Staff Reviewing Elon Musk's Neuralink: 'We Should Be Worried About The Whole Trial,' Says Former Official
Via Benzinga
Exposures Product Safety
Tickers TSLA
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at 6th Glioblastoma Drug Development Summit
Via Investor Brand Network
Exposures Product Safety
Tickers CNSP
Axsome's AXS-05 In Alzheimer's Agitation Could Be Billion Dollar Opportunity, Says Analyst
Via Benzinga
Exposures Product Safety
Tickers AXSM ITCI JNJ
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Provisional Patent for SPC-15 Dual-Action Treatment
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers SILO
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.